ETNB•benzinga•
89bio Will Present 48-Week Data From ENLIVEN Phase 2b Pegozafermin Trial In MASH At EASL International Liver Congress
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 22, 2024 by benzinga